Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses
-
Published:2023-02-13
Issue:2
Volume:15
Page:625
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Pelusi Letizia1, Mandatori Domitilla1, Mastropasqua Leonardo2, Agnifili Luca2, Allegretti Marcello3ORCID, Nubile Mario2, Pandolfi Assunta1ORCID
Affiliation:
1. Department of Medical, Oral and Biotechnological Sciences, Center for Advanced Studies and Technology-CAST, StemTeCh Group, University G. D’Annunzio of Chieti-Pescara, 66100 Chieti, Italy 2. Department of Medicine and Aging Science, Ophthalmology Clinic, University G. D’Annunzio of Chieti-Pescara, 66100 Chieti, Italy 3. Dompé Farmaceutici SpA, Via Campo di Pile, 67100 L’Aquila, Italy
Abstract
Nowadays, ocular drug delivery still remains a challenge, since the conventional dosage forms used for anterior and posterior ocular disease treatments, such as topical, systemic, and intraocular administration methods, present important limitations mainly related to the anatomical complexity of the eye. In particular, the blood–ocular barrier along with the corneal barrier, ocular surface, and lacrimal fluid secretion reduce the availability of the administered active compounds and their efficacy. These limitations have increased the need to develop safe and effective ocular delivery systems able to sustain the drug release in the interested ocular segment over time. In the last few years, thanks to the innovations in the materials and technologies employed, different ocular drug delivery systems have been developed. Therefore, this review aims to summarize the synthetic and natural drug-loaded ocular inserts, contacts, and intraocular lenses that have been recently developed, emphasizing the characteristics that make them promising for future ocular clinical applications.
Subject
Pharmaceutical Science
Reference116 articles.
1. Tsai, C.-H., Wang, P.-Y., Lin, I.-C., Huang, H., Liu, G.-S., and Tseng, C.-L. (2018). Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application. Int. J. Mol. Sci., 19. 2. Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., and Otero-Espinar, F.J. (2020). Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics, 12. 3. Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives;Gaballa;Drug Deliv. Transl. Res.,2020 4. Drug delivery to the posterior segment of the eye;Thrimawithana;Drug Discov. Today,2011 5. Ocular Drug Delivery: Present Innovations and Future Challenges;Gote;J. Pharmacol. Exp. Ther.,2019
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|